Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Nanotechnology in reproductive medicine: Opportunities for clinical translation

Clinical and Experimental Reproductive Medicine 2020³â 47±Ç 4È£ p.245 ~ 262
Shandilya Ruchita, Pathak Neelam, Lohiya Nirmal Kumar, Sharma Radhey Shyam, Mishra Pradyumna Kumar,
¼Ò¼Ó »ó¼¼Á¤º¸
 ( Shandilya Ruchita ) 
ICMR-National Institute for Research in Environmental Health Department of Molecular Biology

 ( Pathak Neelam ) 
University of Rajasthan School of Life Sciences
 ( Lohiya Nirmal Kumar ) 
University of Rajasthan School of Life Sciences
 ( Sharma Radhey Shyam ) 
Indian Council of Medical Research Division of Reproductive Biology, Maternal and Child Health
 ( Mishra Pradyumna Kumar ) 
ICMR-National Institute for Research in Environmental Health Department of Molecular Biology

Abstract


In recent years, nanotechnology has revolutionized global healthcare and has been predicted to exert a remarkable effect on clinical medicine. In this context, the clinical use of nanomaterials for cancer diagnosis, fertility preservation, and the management of infertility and other pathologies linked to pubertal development, menopause, sexually transmitted infections, and HIV (human immunodeficiency virus) has substantial promise to fill the existing lacunae in reproductive healthcare. Of late, a number of clinical trials involving the use of nanoparticles for the early detection of reproductive tract infections and cancers, targeted drug delivery, and cellular therapeutics have been conducted. However, most of these trials of nanoengineering are still at a nascent stage, and better synergy between pharmaceutics, chemistry, and cutting-edge molecular sciences is needed for effective translation of these interventions from bench to bedside. To bridge the gap between translational outcome and product development, strategic partnerships with the insight and ability to anticipate challenges, as well as an in-depth understanding of the molecular pathways involved, are highly essential. Such amalgamations would overcome the regulatory gauntlet and technical hurdles, thereby facilitating the effective clinical translation of these nano-based tools and technologies. The present review comprehensively focuses on emerging applications of nanotechnology, which holds enormous promise for improved therapeutics and early diagnosis of various human reproductive tract diseases and conditions.

Å°¿öµå

Nanomedicine; Nanosensors; Nanotherapy; Reproductive health; Translational research

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS